It has been reported that the ablation of Apo-AI genetically in mice increased the cerebral amyloid activity deposits in the brain, and it worsened the memory in mice, which supported the hypothesis of an association of low levels of HDL cholesterol with dementia [14]. Here, APOA1 is linked to dementia.